MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2021 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
6.28 M |
Market Cap[1] |
$ 144 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Olema Pharmaceuticals
OLMA
|
$ 7.54 | 2.59 % | $ 656 M | Nasdaq Global Select Market | USA |
 |
Kymera Therapeutics
KYMR
|
$ 134.83 | 6.09 % | $ 11.4 B | Nasdaq Global Market | USA |
 |
Oragenics
OGEN
|
$ 0.38 | 1.35 % | $ 820 K | NYSE American | USA |
 |
Ovid Therapeutics
OVID
|
$ 2.75 | 14.37 % | $ 358 M | Nasdaq Global Select Market | USA |
 |
Passage Bio
PASG
|
$ 3.51 | 3.24 % | $ 11.3 M | Nasdaq Global Select Market | USA |
 |
Vaxcyte
PCVX
|
$ 65.67 | 7.99 % | $ 8.94 B | Nasdaq Global Select Market | USA |
 |
Precigen
PGEN
|
$ 5.05 | -3.76 % | $ 1.58 B | Nasdaq Global Select Market | USA |
 |
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.86 | -4.65 % | $ 5.15 M | Nasdaq Capital Market | USA |
 |
Praxis Precision Medicines
PRAX
|
$ 284.45 | 1.4 % | $ 6.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Prelude Therapeutics Incorporated
PRLD
|
$ 4.08 | 7.94 % | $ 314 M | Nasdaq Global Select Market | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
$ 1.41 | 2.55 % | $ 149 M | Nasdaq Global Market |  Niderland |
 |
Ocular Therapeutix
OCUL
|
$ 7.14 | 4.69 % | $ 1.34 B | Nasdaq Global Select Market | USA |
 |
PolyPid Ltd.
PYPD
|
$ 5.69 | 4.21 % | $ 93 M | Nasdaq Global Select Market |  Israel |
 |
Outlook Therapeutics
OTLK
|
$ 0.46 | -0.8 % | $ 16 M | Nasdaq Global Select Market | USA |
 |
uniQure N.V.
QURE
|
$ 23.04 | -3.48 % | $ 1.32 B | Nasdaq Global Select Market | Niderland |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 17.14 | 3.07 % | $ 1.69 B | Nasdaq Global Select Market,SPB | USA |
 |
Regeneron Pharmaceuticals
REGN
|
$ 931.5 | -4.3 % | $ 97.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Rafael Holdings
RFL
|
$ 1.1 | 1.97 % | $ 56.5 M | NYSE | USA |
 |
REGENXBIO
RGNX
|
$ 7.61 | -0.33 % | $ 392 M | Nasdaq Global Select Market,SPB | USA |
 |
China SXT Pharmaceuticals
SXTC
|
$ 3.0 | 4.17 % | $ 2.04 M | Nasdaq Global Select Market |  China |
 |
Rigel Pharmaceuticals
RIGL
|
$ 51.18 | 4.75 % | $ 921 M | Nasdaq Global Select Market | USA |
 |
Celsion Corporation
CLSN
|
- | -6.63 % | $ 13.9 M | Nasdaq Capital Market | USA |
 |
Генетико
GECO
|
- | - | - | MOEX |  Russia |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market | China |
 |
Tenax Therapeutics
TENX
|
$ 1.79 | -2.99 % | $ 70.2 M | Nasdaq Global Select Market | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market |  France |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Scholar Rock Holding Corporation
SRRK
|
$ 46.06 | 4.73 % | $ 5.28 B | Nasdaq Global Select Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market |  Germany |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
- | 0.74 % | $ 768 M | Nasdaq Capital Market | Israel |
 |
Abcam plc
ABCM
|
- | - | $ 4.9 B | Nasdaq Global Select Market |  Britain |
 |
Rezolute
RZLT
|
$ 3.97 | -1.12 % | $ 413 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
Tiziana Life Sciences PLC
TLSA
|
$ 0.64 | -7.06 % | $ 68.3 M | Nasdaq Global Market | Britain |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | Germany |
 |
Affimed N.V.
AFMD
|
- | -34.95 % | $ 21.5 M | Nasdaq Global Select Market,SPB | Germany |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 1.71 | -1.16 % | $ 1.15 B | Nasdaq Capital Market | Israel |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
- | -1.58 % | $ 28.1 M | Nasdaq Global Market | China |
 |
Celyad Oncology SA
CYAD
|
- | - | $ 12.5 M | Nasdaq Global Market |  Belgium |
 |
Seer
SEER
|
$ 1.71 | -1.45 % | $ 94.4 M | Nasdaq Global Select Market | USA |
 |
Gracell Biotechnologies
GRCL
|
- | - | $ 3.37 B | Nasdaq Global Select Market | China |
 |
Trevi Therapeutics
TRVI
|
$ 13.98 | 0.87 % | $ 1.88 B | Nasdaq Global Market | USA |
|
Silence Therapeutics plc
SLN
|
$ 19.8 | 0.1 % | $ 2.81 B | Nasdaq Global Select Market | Britain |
 |
Soligenix
SNGX
|
$ 0.35 | -1.15 % | $ 1.82 M | Nasdaq Capital Market | USA |
 |
Spruce Biosciences
SPRB
|
$ 46.23 | 7.99 % | $ 35.4 M | Nasdaq Global Select Market | USA |
 |
Supernus Pharmaceuticals
SUPN
|
$ 28.24 | 0.32 % | $ 1.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Galapagos NV
GLPG
|
- | - | $ 1.83 B | Nasdaq Global Select Market | Belgium |
 |
Savara
SVRA
|
$ 4.66 | -2.0 % | $ 1.04 B | Nasdaq Global Select Market | USA |
 |
Teligent, Inc.
TLGT
|
- | -13.85 % | $ 16.1 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.